World’s First Lung Cancer Vaccine Comes from Cuba
By Christopher Weaver


Killing 1.4 million people worldwide every year, lung cancer is the most deadly of cancers. Up until now the 5 year survival rate for someone with late-stage lung cancer is around 1%, making this a significant problem that scientists must tackle. Well Gisela Gonzalez at the Center of Molecular Immunology (CIM) in Havana is on the mission and has made some incredible breakthroughs. The team has created the world’s first lung cancer vaccine for patients in stages 3 and 4 that are not responding to conventional methods. It is called CimaVax-EGF which doesn’t claim to cure the cancer, but to minimize the growth by introducing antibodies that help prevent malicious cell growth. This breakthrough comes from 25 years of studying tobacco smokers, but the team hopes to apply their methods to other kinds of serious cancers in the future. It was also of extreme importance in Cuba due to the fact that in 12 out of the 15 provinces lung cancer is the number one cause of death. Here’s a quote from Gisela regarding the vaccine,

“The drug could turn the cancer into a manageable, chronic disease by generating antibodies against the proteins which triggered the uncontrolled cell proliferation. It is not possible to prevent the disease, but this vaccine improves significantly the status of the critically ill patients.”

Via:Medical Xpress

Post Details